J A Cairns

Summary

Affiliation: University of British Columbia
Country: Canada

Publications

  1. doi request reprint Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease
    John A Cairns
    Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
    Can J Cardiol 29:S60-70. 2013
  2. ncbi request reprint Prevention of stroke and systemic embolization in atrial fibrillation: a Canadian perspective
    John A Cairns
    University of British Columbia, Vancouver, British Columbia, Canada
    Pol Arch Med Wewn 122:428-36. 2012
  3. pmc Canadian-led capacity-building in biostatistics and methodology in cardiovascular and diabetes trials: the CANNeCTIN Biostatistics and Methodological Innovation Working Group
    Lehana Thabane
    Department of Clinical Epidemiology and Biostatistics, McMaster University, 1200 Main Street West, Hamilton, Ontario, L8N 3Z5, Canada
    Trials 12:48. 2011
  4. pmc The coxibs and traditional nonsteroidal anti-inflammatory drugs: a current perspective on cardiovascular risks
    J A Cairns
    University of British Columbia, Vancouver, Canada
    Can J Cardiol 23:125-31. 2007
  5. ncbi request reprint Monitoring the ACTIVE-W trial: some issues in monitoring a noninferiority trial
    John A Cairns
    University of British Columbia, Vancouver, British Columbia, Canada
    Am Heart J 155:33-41. 2008
  6. doi request reprint Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter
    John A Cairns
    University of British Columbia, Vancouver, British Columbia, Canada
    Can J Cardiol 27:74-90. 2011
  7. pmc Canadian Network and Centre for Trials Internationally (CANNeCTIN): a national network for Canadian-led trials in cardiovascular diseases and diabetes mellitus
    John A Cairns
    University of British Columbia, Vancouver, British Columbia
    Can J Cardiol 26:353-8. 2010
  8. ncbi request reprint Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study
    J A Cairns
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Circulation 94:1553-60. 1996
  9. doi request reprint Clopidogrel resistance: more grist for the mill
    John A Cairns
    J Am Coll Cardiol 51:1935-7. 2008
  10. ncbi request reprint Long-term amiodarone therapy and the risk of complications after cardiac surgery: results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT)
    Eugene Crystal
    Department of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
    J Thorac Cardiovasc Surg 125:633-7. 2003

Collaborators

Detail Information

Publications11

  1. doi request reprint Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease
    John A Cairns
    Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
    Can J Cardiol 29:S60-70. 2013
    ..In the absence of definitive trials of combination therapies, such practice guidelines are based on extrapolations from randomized trials and observational data. ..
  2. ncbi request reprint Prevention of stroke and systemic embolization in atrial fibrillation: a Canadian perspective
    John A Cairns
    University of British Columbia, Vancouver, British Columbia, Canada
    Pol Arch Med Wewn 122:428-36. 2012
    ..Recent clinical practice guidelines recommend these agents as alternatives to VKAs...
  3. pmc Canadian-led capacity-building in biostatistics and methodology in cardiovascular and diabetes trials: the CANNeCTIN Biostatistics and Methodological Innovation Working Group
    Lehana Thabane
    Department of Clinical Epidemiology and Biostatistics, McMaster University, 1200 Main Street West, Hamilton, Ontario, L8N 3Z5, Canada
    Trials 12:48. 2011
    ..The ultimate goal is to enhance global health by contributing to efforts to reduce the burden of CVD and DM...
  4. pmc The coxibs and traditional nonsteroidal anti-inflammatory drugs: a current perspective on cardiovascular risks
    J A Cairns
    University of British Columbia, Vancouver, Canada
    Can J Cardiol 23:125-31. 2007
    ..Current recommendations for the ongoing use of coxibs and the tNSAIDs are summarized...
  5. ncbi request reprint Monitoring the ACTIVE-W trial: some issues in monitoring a noninferiority trial
    John A Cairns
    University of British Columbia, Vancouver, British Columbia, Canada
    Am Heart J 155:33-41. 2008
    ....
  6. doi request reprint Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter
    John A Cairns
    University of British Columbia, Vancouver, British Columbia, Canada
    Can J Cardiol 27:74-90. 2011
    ..Alternatives to antithrombotic therapies are briefly discussed...
  7. pmc Canadian Network and Centre for Trials Internationally (CANNeCTIN): a national network for Canadian-led trials in cardiovascular diseases and diabetes mellitus
    John A Cairns
    University of British Columbia, Vancouver, British Columbia
    Can J Cardiol 26:353-8. 2010
    ....
  8. ncbi request reprint Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty. The EMPAR Study
    J A Cairns
    Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Circulation 94:1553-60. 1996
    ..Low-molecular-weight heparin (LMWH) has reduced cellular proliferation and restenosis in several experimental systems...
  9. doi request reprint Clopidogrel resistance: more grist for the mill
    John A Cairns
    J Am Coll Cardiol 51:1935-7. 2008
  10. ncbi request reprint Long-term amiodarone therapy and the risk of complications after cardiac surgery: results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT)
    Eugene Crystal
    Department of Medicine, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada
    J Thorac Cardiovasc Surg 125:633-7. 2003
    ....
  11. ncbi request reprint Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in preventive cardiology: which drug to use and what to expect in light of the ONTARGET trial
    John A Cairns
    Pol Arch Med Wewn 118:335-8. 2008